56 results
Page 2 of 3
8-K
EX-99.1
31i8zau
28 Apr 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
mwn4dtbf5ib 6xkjn
6 Jan 21
Regulation FD Disclosure
7:05am
S-3
EX-1.2
exq43cv
1 Dec 20
Shelf registration
5:21pm
S-3
r2a0yez9z32ejeuovg
1 Dec 20
Shelf registration
5:21pm
8-K
EX-99.2
ozwov
10 Nov 20
Galera Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business Updates
7:07am
8-K
EX-3.1
yw50amn8 vfit8z
25 Sep 20
Amendments to Articles of Incorporation or Bylaws
4:02pm
DEFA14A
h44238f
27 Apr 20
Additional proxy soliciting materials
7:32am
DEF 14A
f2xph5m70lfcrws
27 Apr 20
Definitive proxy
7:30am
10-K
1767on0jkenfj8n 6s
10 Mar 20
Annual report
7:36am
10-Q
vk5q5g1
10 Dec 19
Quarterly report
7:31am
8-K
EX-3.2
niqctnco3v1nerwp0o6d
12 Nov 19
Amendments to Articles of Incorporation or Bylaws
4:58pm
424B4
ca3 rrn7n5y
8 Nov 19
Prospectus supplement with pricing info
4:41pm
S-1/A
EX-1.1
1fi4q 1zp
28 Oct 19
IPO registration (amended)
7:16am
S-1/A
EX-10.2
evxemh6r
28 Oct 19
IPO registration (amended)
7:16am
S-1/A
EX-10.4
93e2uy 3doa3h6a
28 Oct 19
IPO registration (amended)
7:16am
S-1/A
mbj77n sphrs
28 Oct 19
IPO registration (amended)
7:16am
S-1/A
EX-4.2
mub26ua3vjmal
28 Oct 19
IPO registration (amended)
7:16am